Calcineurin stimulation by Cnb1p overproduction mitigates protein aggregation and α-synuclein toxicity in a yeast model of synucleinopathy.


Journal

Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464

Informations de publication

Date de publication:
24 08 2023
Historique:
received: 06 05 2023
accepted: 22 07 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

The calcium-responsive phosphatase, calcineurin, senses changes in Ca

Identifiants

pubmed: 37620860
doi: 10.1186/s12964-023-01242-w
pii: 10.1186/s12964-023-01242-w
pmc: PMC10464345
doi:

Substances chimiques

alpha-Synuclein 0
Protein Aggregates 0
Calcineurin EC 3.1.3.16
CRZ1 protein, S cerevisiae 0
DNA-Binding Proteins 0
Transcription Factors 0
Saccharomyces cerevisiae Proteins 0

Types de publication

Video-Audio Media Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Viladevall L, Serrano R, Ruiz A, Domenech G, Giraldo J, Barcelo A, et al. Characterization of the calcium-mediated response to alkaline stress in Saccharomyces cerevisiae. J Biol Chem. 2004;279(42):43614–24.
pubmed: 15299026
Cunningham KW. Acidic calcium stores of Saccharomyces cerevisiae. Cell Calcium. 2011;50(2):129–38.
pubmed: 21377728 pmcid: 3137693
Cyert MS, Philpott CC. Regulation of cation balance in Saccharomyces cerevisiae. Genetics. 2013;193(3):677–713.
pubmed: 23463800 pmcid: 3583992
Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 1997;386(6627):855–8.
pubmed: 9126747
Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–29.
pubmed: 12838335
Goldman A, Roy J, Bodenmiller B, Wanka S, Landry CR, Aebersold R, et al. The calcineurin signaling network evolves via conserved kinase-phosphatase modules that transcend substrate identity. Mol Cell. 2014;55(3):422–35.
pubmed: 24930733 pmcid: 4127121
Arsenault HE, Roy J, Mapa CE, Cyert MS, Benanti JA. Hcm1 integrates signals from Cdk1 and calcineurin to control cell proliferation. Mol Biol Cell. 2015;26(20):3570–7.
pubmed: 26269584 pmcid: 4603928
Guiney EL, Goldman AR, Elias JE, Cyert MS. Calcineurin regulates the yeast synaptojanin Inp53/Sjl3 during membrane stress. Mol Biol Cell. 2015;26(4):769–85.
pubmed: 25518934 pmcid: 4325846
Saneyoshi T, Kume S, Amasaki Y, Mikoshiba K. The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature. 2002;417(6886):295–9.
pubmed: 12015605
Nishiyama T, Yoshizaki N, Kishimoto T, Ohsumi K. Transient activation of calcineurin is essential to initiate embryonic development in Xenopus laevis. Nature. 2007;449(7160):341–5.
pubmed: 17882220
Dwivedi M, Song HO, Ahnn J. Autophagy genes mediate the effect of calcineurin on life span in C. elegans. Autophagy. 2009;5(5):604–7.
pubmed: 19279398
Mair W, Morantte I, Rodrigues AP, Manning G, Montminy M, Shaw RJ, et al. Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature. 2011;470(7334):404–8.
pubmed: 21331044 pmcid: 3098900
Nakai Y, Horiuchi J, Tsuda M, Takeo S, Akahori S, Matsuo T, et al. Calcineurin and its regulator sra/DSCR1 are essential for sleep in Drosophila. J Neurosci. 2011;31(36):12759–66.
pubmed: 21900555 pmcid: 6623415
Lee JI, Mukherjee S, Yoon KH, Dwivedi M, Bandyopadhyay J. The multiple faces of calcineurin signaling in Caenorhabditis elegans: development, behaviour and aging. J Biosci. 2013;38(2):417–31.
pubmed: 23660677
Kujawski S, Lin W, Kitte F, Bormel M, Fuchs S, Arulmozhivarman G, et al. Calcineurin regulates coordinated outgrowth of zebrafish regenerating fins. Dev Cell. 2014;28(5):573–87.
pubmed: 24561038
Deng H, Gerencser AA, Jasper H. Signal integration by Ca(2+) regulates intestinal stem-cell activity. Nature. 2015;528(7581):212–7.
pubmed: 26633624 pmcid: 4669953
Caraveo G, Auluck PK, Whitesell L, Chung CY, Baru V, Mosharov EV, et al. Calcineurin determines toxic versus beneficial responses to alpha-synuclein. Proc Natl Acad Sci U S A. 2014;111(34):E3544–52.
pubmed: 25122673 pmcid: 4151770
Angelova PR, Ludtmann MH, Horrocks MH, Negoda A, Cremades N, Klenerman D, et al. Ca2+ is a key factor in alpha-synuclein-induced neurotoxicity. J Cell Sci. 2016;129(9):1792–801.
pubmed: 26989132 pmcid: 4893653
Lieberman OJ, Choi SJ, Kanter E, Saverchenko A, Frier MD, Fiore GM, et al. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin. eNeuro. 2017;4(6):ENEURO.0167-17.2017.
Betzer C, Jensen PH. Reduced cytosolic calcium as an early decisive cellular state in Parkinson’s disease and synucleinopathies. Front Neurosci. 2018;12:819.
pubmed: 30459551 pmcid: 6232531
Habernig L, Broeskamp F, Aufschnaiter A, Diessl J, Peselj C, Urbauer E, et al. Ca2+ administration prevents alpha-synuclein proteotoxicity by stimulating calcineurin-dependent lysosomal proteolysis. PLoS Genet. 2021;17(11):e1009911.
pubmed: 34780474 pmcid: 8629384
Erjavec N, Larsson L, Grantham J, Nystrom T. Accelerated aging and failure to segregate damaged proteins in Sir2 mutants can be suppressed by overproducing the protein aggregation-remodeling factor Hsp104p. Genes Dev. 2007;21(19):2410–21.
pubmed: 17908928 pmcid: 1993872
Spokoini R, Moldavski O, Nahmias Y, England JL, Schuldiner M, Kaganovich D. Confinement to organelle-associated inclusion structures mediates asymmetric inheritance of aggregated protein in budding yeast. Cell Rep. 2012;2(4):738–47.
pubmed: 23022486
Babazadeh R, Ahmadpour D, Jia S, Hao X, Widlund P, Schneider K, et al. Syntaxin 5 is required for the formation and clearance of protein inclusions during proteostatic stress. Cell Rep. 2019;28(8):2096-110 e8.
pubmed: 31433985
Schneider KL, Ahmadpour D, Keuenhof KS, Eisele-Burger AM, Berglund LL, Eisele F, et al. Using reporters of different misfolded proteins reveals differential strategies in processing protein aggregates. J Biol Chem. 2022;298(11):102476.
pubmed: 36096201 pmcid: 9636550
Comyn SA, Young BP, Loewen CJ, Mayor T. Prefoldin promotes proteasomal degradation of cytosolic proteins with missense mutations by maintaining substrate solubility. PLoS Genet. 2016;12(7):e1006184.
pubmed: 27448207 pmcid: 4957761
Kingsbury TJ, Cunningham KW. A conserved family of calcineurin regulators. Genes Dev. 2000;14(13):1595–604.
pubmed: 10887154 pmcid: 316734
Geiser JR, van Tuinen D, Brockerhoff SE, Neff MM, Davis TN. Can calmodulin function without binding calcium? Cell. 1991;65(6):949–59.
pubmed: 2044154
Diessl J, Nandy A, Schug C, Habernig L, Büttner S. Stable and destabilized GFP reporters to monitor calcineurin activity in Saccharomyces cerevisiae. Microb Cell. 2020;7(4):106–14. https://doi.org/10.15698/mic2020.04.713 .
Kaganovich D, Kopito R, Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature. 2008;454(7208):1088–95.
pubmed: 18756251 pmcid: 2746971
Specht S, Miller SB, Mogk A, Bukau B. Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol. 2011;195(4):617–29.
pubmed: 22065637 pmcid: 3257523
Malinovska L, Kroschwald S, Munder MC, Richter D, Alberti S. Molecular chaperones and stress-inducible protein-sorting factors coordinate the spatiotemporal distribution of protein aggregates. Mol Biol Cell. 2012;23(16):3041–56.
pubmed: 22718905 pmcid: 3418301
Xu H, Fang T, Yan H, Jiang L. The protein kinase Cmk2 negatively regulates the calcium/calcineurin signalling pathway and expression of calcium pump genes PMR1 and PMC1 in budding yeast. Cell Commun Signal. 2019;17(1):7.
pubmed: 30665402 pmcid: 6341702
Smeal T, Claus J, Kennedy B, Cole F, Guarente L. Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. Cell. 1996;84(4):633–42.
pubmed: 8598049
Sinclair DA, Guarente L. Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol. 2014;54:363–80.
pubmed: 24160699
Eilam Y, Lavi H, Grossowicz N. Mechanism of stimulation of Ca2+ uptake by miconazole and ethidium bromide in yeasts: role of vacuoles in Ca2+ detoxification. Microbios. 1985;44(177):51–66.
pubmed: 2870412
Dunn T, Gable K, Beeler T. Regulation of cellular Ca2+ by yeast vacuoles. J Biol Chem. 1994;269(10):7273–8.
pubmed: 8125940
Sorin A, Rosas G, Rao R. PMR1, a Ca2+-ATPase in yeast Golgi, has properties distinct from sarco/endoplasmic reticulum and plasma membrane calcium pumps. J Biol Chem. 1997;272(15):9895–901.
pubmed: 9092527
Durr G, Strayle J, Plemper R, Elbs S, Klee SK, Catty P, et al. The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol Biol Cell. 1998;9(5):1149–62.
pubmed: 9571246 pmcid: 25337
Strayle J, Pozzan T, Rudolph HK. Steady-state free Ca(2+) in the yeast endoplasmic reticulum reaches only 10 microM and is mainly controlled by the secretory pathway pump pmr1. EMBO J. 1999;18(17):4733–43.
pubmed: 10469652 pmcid: 1171546
Cagnac O, Aranda-Sicilia MN, Leterrier M, Rodriguez-Rosales MP, Venema K. Vacuolar cation/H+ antiporters of Saccharomyces cerevisiae. J Biol Chem. 2010;285(44):33914–22.
pubmed: 20709757 pmcid: 2962491
Callewaert G, D’Hooge P, Ma TY, Del Vecchio M, Van Eyck V, Franssens V, et al. Decreased vacuolar Ca(2+) storage and disrupted vesicle trafficking underlie alpha-synuclein-induced Ca(2+) dysregulation in S. cerevisiae. Front Genet. 2020;11:266.
pubmed: 32457789 pmcid: 7225347
Denis V, Cyert MS. Internal Ca(2+) release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J Cell Biol. 2002;156(1):29–34.
pubmed: 11781332 pmcid: 2173594
O’Donnell AF, Apffel A, Gardner RG, Cyert MS. Alpha-arrestins Aly1 and Aly2 regulate intracellular trafficking in response to nutrient signaling. Mol Biol Cell. 2010;21(20):3552–66.
pubmed: 20739461 pmcid: 2954120
O’Donnell AF, Huang L, Thorner J, Cyert MS. A calcineurin-dependent switch controls the trafficking function of alpha-arrestin Aly1/Art6. J Biol Chem. 2013;288(33):24063–80.
pubmed: 23824189 pmcid: 3745350
Berchtold D, Piccolis M, Chiaruttini N, Riezman I, Riezman H, Roux A, et al. Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis. Nat Cell Biol. 2012;14(5):542–7.
pubmed: 22504275
Bultynck G, Heath VL, Majeed AP, Galan JM, Haguenauer-Tsapis R, Cyert MS. Slm1 and slm2 are novel substrates of the calcineurin phosphatase required for heat stress-induced endocytosis of the yeast uracil permease. Mol Cell Biol. 2006;26(12):4729–45.
pubmed: 16738335 pmcid: 1489119
Heath VL, Shaw SL, Roy S, Cyert MS. Hph1p and Hph2p, novel components of calcineurin-mediated stress responses in Saccharomyces cerevisiae. Eukaryot Cell. 2004;3(3):695–704.
pubmed: 15189990 pmcid: 420127
Pina FJ, O’Donnell AF, Pagant S, Piao HL, Miller JP, Fields S, et al. Hph1 and Hph2 are novel components of the Sec63/Sec62 posttranslational translocation complex that aid in vacuolar proton ATPase biogenesis. Eukaryot Cell. 2011;10(1):63–71.
pubmed: 21097665 pmcid: 3019806
Matheos DP, Kingsbury TJ, Ahsan US, Cunningham KW. Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. Genes Dev. 1997;11(24):3445–58.
pubmed: 9407036 pmcid: 316804
Stathopoulos AM, Cyert MS. Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev. 1997;11(24):3432–44.
pubmed: 9407035 pmcid: 316814
Stathopoulos-Gerontides A, Guo JJ, Cyert MS. Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev. 1999;13(7):798–803.
pubmed: 10197980 pmcid: 316598
Hill SM, Hao X, Gronvall J, Spikings-Nordby S, Widlund PO, Amen T, et al. Asymmetric inheritance of aggregated proteins and age reset in yeast are regulated by Vac17-dependent vacuolar functions. Cell Rep. 2016;16(3):826–38.
pubmed: 27373154 pmcid: 4963537
Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science. 2003;302(5651):1772–5.
pubmed: 14657500 pmcid: 1780172
Dixon C, Mathias N, Zweig RM, Davis DA, Gross DS. Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics. 2005;170(1):47–59.
pubmed: 15744056 pmcid: 1449710
Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science. 2003;302(5651):1769–72.
pubmed: 14657499
Bussell R Jr, Eliezer D. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol. 2003;329(4):763–78.
pubmed: 12787676
Liang J, Clark-Dixon C, Wang S, Flower TR, Williams-Hart T, Zweig R, et al. Novel suppressors of alpha-synuclein toxicity identified using yeast. Hum Mol Genet. 2008;17(23):3784–95.
pubmed: 18772193 pmcid: 2581432
Zabrocki P, Bastiaens I, Delay C, Bammens T, Ghillebert R, Pellens K, et al. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim Biophys Acta. 2008;1783(10):1767–80.
pubmed: 18634833
Yeger-Lotem E, Riva L, Su LJ, Gitler AD, Cashikar AG, King OD, et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat Genet. 2009;41(3):316–23.
pubmed: 19234470 pmcid: 2733244
Ruiperez V, Darios F, Davletov B. Alpha-synuclein, lipids and Parkinson’s disease. Prog Lipid Res. 2010;49(4):420–8.
pubmed: 20580911
Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14(1):38–48.
pubmed: 23254192 pmcid: 4295774
Galvagnion C. The role of lipids interacting with alpha-synuclein in the pathogenesis of Parkinson’s disease. J Parkinsons Dis. 2017;7(3):433–50.
pubmed: 28671142
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276(5321):2045–7.
pubmed: 9197268
Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet. 1998;18(2):106–8.
pubmed: 9462735
Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302(5646):841.
pubmed: 14593171
Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet. 2004;364(9440):1167–9.
pubmed: 15451224
Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164–73.
pubmed: 14755719
Tofaris GK, Spillantini MG. Physiological and pathological properties of alpha-synuclein. Cell Mol Life Sci. 2007;64(17):2194–201.
pubmed: 17605001
Auluck PK, Caraveo G, Lindquist S. alpha-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu Rev Cell Dev Biol. 2010;26:211–33.
pubmed: 20500090
Fauvet B, Fares MB, Samuel F, Dikiy I, Tandon A, Eliezer D, et al. Characterization of semisynthetic and naturally Nalpha-acetylated alpha-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of alpha-synuclein. J Biol Chem. 2012;287(34):28243–62.
pubmed: 22718772 pmcid: 3436566
Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov Disord. 2013;28(6):811–3.
pubmed: 23457019
Lesage S, Anheim M, Letournel F, Bousset L, Honore A, Rozas N, et al. G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol. 2013;73(4):459–71.
pubmed: 23526723
Ghiglieri V, Calabrese V, Calabresi P. Alpha-synuclein: from early synaptic dysfunction to neurodegeneration. Front Neurol. 2018;9:295.
pubmed: 29780350 pmcid: 5945838
Soper JH, Roy S, Stieber A, Lee E, Wilson RB, Trojanowski JQ, et al. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell. 2008;19(3):1093–103.
pubmed: 18172022 pmcid: 2262993
Burre J, Sharma M, Sudhof TC. Definition of a molecular pathway mediating alpha-synuclein neurotoxicity. J Neurosci. 2015;35(13):5221–32.
pubmed: 25834048 pmcid: 4380997
Boustany LM, Cyert MS. Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. Genes Dev. 2002;16(5):608–19.
pubmed: 11877380 pmcid: 155349
Cunningham KW, Fink GR. Calcineurin inhibits VCX1-dependent H+/Ca2+ exchange and induces Ca2+ ATPases in Saccharomyces cerevisiae. Mol Cell Biol. 1996;16(5):2226–37.
pubmed: 8628289 pmcid: 231210
Cyert MS. Genetic analysis of calmodulin and its targets in Saccharomyces cerevisiae. Annu Rev Genet. 2001;35:647–72.
pubmed: 11700296
Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A. 2005;102(30):10427–32.
pubmed: 16020533 pmcid: 1180768
Schmidt F, Levin J, Kamp F, Kretzschmar H, Giese A, Botzel K. Single-channel electrophysiology reveals a distinct and uniform pore complex formed by alpha-synuclein oligomers in lipid membranes. PLoS ONE. 2012;7(8):e42545.
pubmed: 22880029 pmcid: 3411845
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.
pubmed: 28332488
Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, et al. A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes. Yeast. 2004;21(11):947–62.
pubmed: 15334558

Auteurs

Srishti Chawla (S)

Institute for Biomedicine, Sahlgrenska Academy, Centre for Ageing and Health - AgeCap, University of Gothenburg, Gothenburg, 405 30, Sweden. srishti@chalmers.se.
Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden. srishti@chalmers.se.

Doryaneh Ahmadpour (D)

Center for Bionics and Pain Research, Sahlgrenska University Hospital, Mölndal, 431 30, Sweden.

Kara L Schneider (KL)

Institute for Biomedicine, Sahlgrenska Academy, Centre for Ageing and Health - AgeCap, University of Gothenburg, Gothenburg, 405 30, Sweden.

Navinder Kumar (N)

Institute for Biomedicine, Sahlgrenska Academy, Centre for Ageing and Health - AgeCap, University of Gothenburg, Gothenburg, 405 30, Sweden.

Arthur Fischbach (A)

Max Planck Institute for Biology of Ageing, Cologne, 50931, Germany.

Mikael Molin (M)

Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.

Thomas Nystrom (T)

Institute for Biomedicine, Sahlgrenska Academy, Centre for Ageing and Health - AgeCap, University of Gothenburg, Gothenburg, 405 30, Sweden. thomas.nystrom@cmb.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH